US 12221607
Multi-targeted single entity conjugates
granted A61KA61K47/549A61K47/55
Quick answer
US patent 12221607 (Multi-targeted single entity conjugates) held by Alnylam Pharmaceuticals, Inc. expires Mon Feb 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Feb 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K47/549, A61K47/55